Altoida

Detecting an MCI and Amyloid Digital Neuro Signature (DNS) using Altoida’s multimodal digital biomarkers. Ground Truth data collection.

To be eligible for this study, a potential participant must:

Male or female, 50+ years at the time of consent.
At least four years of formal education (from primary school onwards).
Adequate vision to complete the Ground Truth assessment and neuropsychological tests with or without corrective lenses.
Has Not been in a clinical trial longer than six months of any potential disease-modifying anti-amyloid AD treatment.

"*" indicates required fields

Step 1 of 3

Submit your interest to our team of specialists

Attention: Make sure to check that you fit the eligibility requirements.

First Name*

Last Name*

Email*

Phone Number*